Gene · 8793
Papers1,762
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,762
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy. | Front Oncol | 2022 | 35299751 | PubTator, text mining | PubMed |
| The Role of CCN1 in Esophageal Adenocarcinoma: What We Have Learned From the Lab. | Cancer Control | 2022 | 35291889 | PubTator, text mining | PubMed |
| Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells. | Front Cell Dev Biol | 2022 | 35281089 | PubTator, text mining | PubMed |
| Unspecific CTL Killing Is Enhanced by High Glucose via TNF-Related Apoptosis-Inducing Ligand. | Front Immunol | 2022 | 35265081 | PubTator, text mining | PubMed |
| Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development. | Front Cell Dev Biol | 2022 | 35252191 | PubTator, text mining | PubMed |
| Probiotic normalization of systemic inflammation in siblings of type 1 diabetes patients: an open-label pilot study. | Sci Rep | 2022 | 35228584 | PubTator, text mining | PubMed |
| Synergistic Effects of Toll-Like Receptor 1/2 and Toll-Like Receptor 3 Signaling Triggering Interleukin 27 Gene Expression in Chikungunya Virus-Infected Macrophages. | Front Cell Dev Biol | 2022 | 35223841 | PubTator, text mining | PubMed |
| Alzheimer's disease protease-containing plasma extracellular vesicles transfer to the hippocampus via the choroid plexus. | EBioMedicine | 2022 | 35220044 | PubTator, text mining | PubMed |
| Macrophage-like THP-1 Cells Derived from High-Density Cell Culture Are Resistant to TRAIL-Induced Cell Death via Down-Regulation of Death-Receptors DR4 and DR5. | Biomolecules | 2022 | 35204655 | PubTator, text mining | PubMed |
| Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma. | Cancer Cell Int | 2022 | 35193632 | PubTator, text mining | PubMed |
| Effluent decoy receptor 2 as a novel biomarker of peritoneal fibrosis in peritoneal dialysis patients. | Perit Dial Int | 2022 | 35176936 | PubTator, text mining | PubMed |
| Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human Cancer Cells, HeLa. | Int J Mol Sci | 2022 | 35163629 | PubTator, text mining | PubMed |
| Navigating a complex landscape - A review of the relationship between inflammation and childhood trauma and the potential roles in the expression of symptoms of depression. | Brain Behav Immun Health | 2022 | 35146459 | PubTator, text mining | PubMed |
| Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions. | Microvasc Res | 2022 | 35143811 | PubTator, text mining | PubMed |
| New Approach about the Signaling Crosstalk between IQGAPs/ NF- κB/IL-8 and PDCD5/p53/TRAIL Pathways that Modulate Malignant Transformation in Hepatocellular Carcinoma. | Asian Pac J Cancer Prev | 2022 | 35092397 | PubTator, text mining | PubMed |
| Characterization of the COPD alveolar niche using single-cell RNA sequencing. | Nat Commun | 2022 | 35078977 | PubTator, text mining | PubMed |
| Transcriptome of visceral adipose tissue identifies an inflammation-related ceRNA network that regulates obesity. | Mol Cell Biochem | 2022 | 35064875 | PubTator, text mining | PubMed |
| Receptor Specificity Engineering of TNF Superfamily Ligands. | Pharmaceutics | 2022 | 35057080 | PubTator, text mining | PubMed |
| Identification of a Potent Cytotoxic Pyrazole with Anti-Breast Cancer Activity That Alters Multiple Pathways. | Cells | 2022 | 35053370 | PubTator, text mining | PubMed |
| Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer. | Onco Targets Ther | 2022 | 35035222 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8793/papers?page=12